|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$82,036.96 |
2.78% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$80,607.98 |
2.73% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$77,801.01 |
2.63% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,858.00 |
2.57% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$72,368.55 |
2.45% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$70,594.65 |
2.39% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$69,806.69 |
2.36% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$68,514.67 |
2.32% |
| Waters Corporation |
WAT |
941848103 |
184 |
$67,892.32 |
2.30% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$67,810.10 |
2.29% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$67,438.98 |
2.28% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,035.78 |
2.27% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$65,891.94 |
2.23% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$65,002.37 |
2.20% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$64,897.61 |
2.20% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$64,887.28 |
2.20% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$64,219.96 |
2.17% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$63,927.36 |
2.16% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$63,187.30 |
2.14% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$62,832.64 |
2.13% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$62,678.37 |
2.12% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$62,278.22 |
2.11% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$61,044.50 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$60,420.94 |
2.04% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$60,098.40 |
2.03% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$59,375.88 |
2.01% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$59,199.84 |
2.00% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$58,950.90 |
1.99% |
| Steris Plc |
STE |
G8473T100 |
265 |
$57,727.60 |
1.95% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$57,678.96 |
1.95% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,746.91 |
1.92% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,660.96 |
1.92% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,117.43 |
1.90% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$56,243.20 |
1.90% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$55,657.38 |
1.88% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$54,469.42 |
1.84% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$53,523.24 |
1.81% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$53,103.57 |
1.80% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$52,237.82 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$51,339.42 |
1.74% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$50,897.49 |
1.72% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$50,204.00 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$49,218.00 |
1.67% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,605.89 |
1.58% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,652.06 |
1.54% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$44,904.60 |
1.52% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$42,218.37 |
1.43% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$42,048.65 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$40,395.85 |
1.37% |
| US Dollar |
$USD |
|
14,881 |
$14,880.63 |
0.50% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|